Clinical Trial Update: Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the combination of interleukin-2 and interferon alfa in adults with metastatic cancer. The study encompassed multiple hematologic and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 2 | Status: COMPLETED